Search results for " biotechnology"
Article
Modeling and Miniaturization: Key Topics at Successful HTPD Conference
The first session also contained one appreciated talk from outside the core field, with Luis Cascão-Pereira from DuPont talking about white biotechnology and process development of enzymes used for wa…
Article
Patenting Prospects for Cell-Based Therapies
Kevin Noonan is partner at McDonnell Boehnen Hulbert & Berghoff LLP and chair of the firm’s biotechnology and pharmaceuticals practice group.
References
1. E. Buz…
Article
Contract Manufacturing Through the Years
A second factor was the explosion of early stage bio/pharma companies, thanks to the maturity of biotechnology and the availability of external funding. Emerging bio/pharma companies rode the coattail…
Poster
Fast Trak Services: a collaborative project to accelerate downstream biosimilar process development
To support this development, mAbxience, a Spanish biotechnology company specialized in research, development, and manufacture of biosimilar drugs, is committed to provide the manufacturing of highqua…
Article
Witnessing Major Growth in Next-Generation Antibodies
More growth expected
Most large pharmaceutical and biotechnology companies have recognized the importance of next-generation antibody therapies and have multiple products under development, whethe…
Article
The Tide Stays High
Equity markets’ appetite for public offerings from emerging bio/pharmaceutical companies had significantly diminished: valuations of emerging bio/pharma companies, as measured by the NASDAQ Biotechnol…
Article
Establishing Acceptance Criteria for Analytical Methods
Knowing how method performance impacts out-of-specification rates may improve quality risk management and product knowledge.
By Thomas A. Little, PhD
To control the consistency and quality o…
Article
A Second Modular Biopharma Facility Opens: KUBio in Hangzhou
To bring advanced biosimilar products to the Chinese market quickly, Pfizer’s Global Biotechnology Center will make use of Cytiva’s KUBio advanced modular manufacturing solution. KUBio modules …
Article
Microbiological Testing: Time is of the Essence
International Council for Harmonisation, Q5A (R1) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin (September 1999).
2. FDA, “FDA issues final rul…
Article
Lessons Learned Accelerate Vaccine Development
…cal company) as the prime and a modified vaccinia Ankara (MVA) vector (MVA-BN technology from Danish biotechnology company Bavarian Nordic) as the boost.
The first GMP batch of its Ebola vaccine …